Cargando…
Access to Drugs for Treatment of Noncommunicable Diseases
Thomas Bollyky explains the emerging controversy over patented medicines for noncommunicable diseases and their affordability in developing countries. Another transformation in global health is required that focuses on low-cost interventions and patient-centered, rather than country-focused, strateg...
Autor principal: | Bollyky, Thomas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720246/ https://www.ncbi.nlm.nih.gov/pubmed/23935456 http://dx.doi.org/10.1371/journal.pmed.1001485 |
Ejemplares similares
-
Strengthening Pandemic Preparedness Through Noncommunicable Disease Strategies
por: Kostova, Deliana A., et al.
Publicado: (2021) -
Noncommunicable Diseases and Injuries in Latin America and the Caribbean: Time for Action
por: Perel, Pablo, et al.
Publicado: (2006) -
Equity and Noncommunicable Disease Reduction under the Sustainable Development Goals
por: Schmidt, Harald, et al.
Publicado: (2015) -
Integration of HIV and Noncommunicable Diseases in Health Care Delivery in Low- and Middle-Income Countries
por: Nigatu, Tilahun
Publicado: (2012) -
Building Noncommunicable Disease Workforce Capacity Through Field Epidemiology Training Programs: Experience From India, 2018–2021
por: Ramalingam, Archana, et al.
Publicado: (2022)